A
23.15
-0.34 (-1.45%)
Previous Close | 23.49 |
Open | 23.46 |
Volume | 67,561 |
Avg. Volume (3M) | 409,110 |
Market Cap | 973,408,896 |
Price / Earnings (Forward) | 588.24 |
Price / Sales | 2.47 |
Price / Book | 3.56 |
52 Weeks Range | |
Earnings Date | 5 May 2025 - 9 May 2025 |
Profit Margin | -3.44% |
Operating Margin (TTM) | 3.96% |
Diluted EPS (TTM) | -0.320 |
Quarterly Revenue Growth (YOY) | 3.90% |
Total Debt/Equity (MRQ) | 131.16% |
Current Ratio (MRQ) | 4.34 |
Operating Cash Flow (TTM) | 22.24 M |
Levered Free Cash Flow (TTM) | 2.33 M |
Return on Assets (TTM) | 2.21% |
Return on Equity (TTM) | -4.79% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Mixed |
Medical Devices (Global) | Bearish | Mixed | |
Stock | Artivion, Inc. | Bullish | Bullish |
AIStockmoo Score
2.1
Analyst Consensus | 5.0 |
Insider Activity | NA |
Price Volatility | 3.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 0.0 |
Average | 2.13 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Growth |
% Held by Insiders | 5.07% |
% Held by Institutions | 91.04% |
52 Weeks Range | ||
Price Target Range | ||
High | 33.00 (JMP Securities, 42.55%) | Buy |
33.00 (Citizens Capital Markets, 42.55%) | Buy | |
Median | 32.50 (40.39%) | |
Low | 30.00 (Stifel, 29.59%) | Buy |
Average | 32.00 (38.23%) | |
Total | 4 Buy | |
Avg. Price @ Call | 24.61 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
JMP Securities | 06 May 2025 | 33.00 (42.55%) | Buy | 23.65 |
Needham | 06 May 2025 | 32.00 (38.23%) | Buy | 23.65 |
25 Feb 2025 | 32.00 (38.23%) | Buy | 25.56 | |
Citizens Capital Markets | 25 Feb 2025 | 33.00 (42.55%) | Buy | 25.56 |
Stifel | 25 Feb 2025 | 30.00 (29.59%) | Buy | 25.56 |
No data within this time range.
Date | Type | Details |
---|---|---|
14 May 2025 | Announcement | Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock |
05 May 2025 | Announcement | Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting |
05 May 2025 | Announcement | Artivion Reports First Quarter 2025 Financial Results |
21 Apr 2025 | Announcement | Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results |
04 Mar 2025 | Announcement | Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference |
24 Feb 2025 | Announcement | Artivion Reports Fourth Quarter and Full Year 2024 Financial Results |
5Y Average Dividend Yield | 0.00% |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
09 Dec 2015 | 22 Oct 2015 | 18 Dec 2015 | 0.03 Cash |
09 Sep 2015 | 22 Jul 2015 | 18 Sep 2015 | 0.03 Cash |
10 Jun 2015 | 21 May 2015 | 19 Jun 2015 | 0.03 Cash |
11 Mar 2015 | 13 Feb 2015 | 20 Mar 2015 | 0.03 Cash |
10 Dec 2014 | 23 Oct 2014 | 19 Dec 2014 | 0.03 Cash |
10 Sep 2014 | 30 Jul 2014 | 19 Sep 2014 | 0.03 Cash |
11 Jun 2014 | 22 May 2014 | 20 Jun 2014 | 0.03 Cash |
12 Mar 2014 | 19 Feb 2014 | 21 Mar 2014 | 0.0275 Cash |
11 Dec 2013 | 21 Nov 2013 | 20 Dec 2013 | 0.0275 Cash |
11 Sep 2013 | 21 Aug 2013 | 20 Sep 2013 | 0.0275 Cash |
12 Jun 2013 | 28 May 2013 | 21 Jun 2013 | 0.0275 Cash |
12 Mar 2013 | 13 Feb 2013 | 21 Mar 2013 | 0.025 Cash |
12 Dec 2012 | 19 Nov 2012 | 21 Dec 2012 | 0.025 Cash |
12 Sep 2012 | 21 Aug 2012 | 21 Sep 2012 | 0.025 Cash |
Show more |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2015 | 0.120 | 4 | 1.11 |
2014 | 0.118 | 4 | 1.04 |
2013 | 0.108 | 4 | 0.97 |
2012 | 0.050 | 2 | 0.80 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |